Delivery Order SPE2DB24D2205-SPE2DB25FECDN
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.92 firm fixed-price delivery order covers the procurement of 4,565,231,057 units of the medication Mycophenolate 500 mg Tablet. The contract has an ultimate completion date of July 24, 2024 and does not contain any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $10,059.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of mycophenolate 500 mg tablets. The contract has a ceiling value of $1,832.60 and a period of performance through August 5, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award, with ID SPE2DB25D3201|SPE2DB25FNSRM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,441.56 firm fixed-price delivery order is for the supply of 4,568,038,058 units of the medication Mycophenolate 500 mg Tablet. The contract has an ultimate completion date of April 28, 2025 and does not utilize a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.52, is a Firm Fixed Price Delivery Order for the supply of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB69E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,294.00 Firm Fixed Price Delivery Order contract is for the supply of 4,567,978,192 units of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,200.99, is for the delivery of 4567764368 - MYCOPHENOLATE 500 MG TABLET 100S. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This appears to be a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,717.88 firm fixed-price delivery order is for the supply of 4,563,279,114 units of mycophenolic acid delayed-release 360 mg tablets in 120-count packages. The contract has a period of performance through January 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for Mycophenolate 500 mg tablets in quantities of 100. The contract has a firm fixed price of $1,630.63 and a completion date of March 1, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp serves as a prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,858.07 firm fixed-price delivery order is for the supply of Mycophenolate 200 mg/ml suspension, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...